These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 36994443)

  • 1. A narrative review of recent literature of the quality of life in hereditary angioedema patients.
    Chong-Neto HJ
    World Allergy Organ J; 2023 Mar; 16(3):100758. PubMed ID: 36994443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study.
    Lumry WR; Zuraw B; Cicardi M; Craig T; Anderson J; Banerji A; Bernstein JA; Caballero T; Farkas H; Gower RG; Keith PK; Levy DS; Li HH; Magerl M; Manning M; Riedl MA; Lawo JP; Prusty S; Machnig T; Longhurst H;
    Orphanet J Rare Dis; 2021 Feb; 16(1):86. PubMed ID: 33588897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary angioedema: Epidemiology and burden of disease.
    Lumry WR; Settipane RA
    Allergy Asthma Proc; 2020 Nov; 41(Suppl 1):S08-S13. PubMed ID: 33109318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of recognizing and managing a rare form of angioedema: hereditary angioedema due to C1-inhibitor deficiency.
    Jacobs J; Neeno T
    Postgrad Med; 2021 Aug; 133(6):639-650. PubMed ID: 33993830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on the Use of C1-Esterase Inhibitor Replacement Therapy in the Acute and Prophylactic Treatment of Hereditary Angioedema.
    Henry Li H; Riedl M; Kashkin J
    Clin Rev Allergy Immunol; 2019 Apr; 56(2):207-218. PubMed ID: 29909591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and burden of illness in patients with hereditary angioedema: findings from a multinational patient survey.
    Mendivil J; Murphy R; de la Cruz M; Janssen E; Boysen HB; Jain G; Aygören-Pürsün E; Hirji I; Devercelli G
    Orphanet J Rare Dis; 2021 Feb; 16(1):94. PubMed ID: 33602292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel prophylaxis with C1-inhibitor concentrate in hereditary angioedema during erythema marginatum.
    Kőhalmi KV; Veszeli N; Cervenak L; Varga L; Farkas H
    Immunol Lett; 2017 Sep; 189():90-93. PubMed ID: 28577900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema.
    Lumry WR; Craig T; Zuraw B; Longhurst H; Baker J; Li HH; Bernstein JA; Anderson J; Riedl MA; Manning ME; Keith PK; Levy DS; Caballero T; Banerji A; Gower RG; Farkas H; Lawo JP; Pragst I; Machnig T; Watson DJ
    J Allergy Clin Immunol Pract; 2018; 6(5):1733-1741.e3. PubMed ID: 29391286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment and management of disease burden and quality of life in patients with hereditary angioedema: a consensus report.
    Bork K; Anderson JT; Caballero T; Craig T; Johnston DT; Li HH; Longhurst HJ; Radojicic C; Riedl MA
    Allergy Asthma Clin Immunol; 2021 Apr; 17(1):40. PubMed ID: 33875020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Content validity of visual analog scales to assess symptom severity of acute angioedema attacks in adults with hereditary angioedema: an interview study.
    McMillan CV; Speight J; Relan A; Bellizzi L; Haase G; Cicardi M
    Patient; 2012; 5(2):113-26. PubMed ID: 22462765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between anxiety and quality of life in children with hereditary angioedema.
    Kessel A; Farkas H; Kivity S; Veszeli N; Kőhalmi KV; Engel-Yeger B
    Pediatr Allergy Immunol; 2017 Nov; 28(7):692-698. PubMed ID: 28692169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic Treatment in Hereditary Angioedema Is Associated with Reduced Anxiety in Patients in Leipzig, Germany.
    Zarnowski J; Rabe M; Kage P; Simon JC; Treudler R
    Int Arch Allergy Immunol; 2021; 182(9):819-826. PubMed ID: 33887730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Letting the patients speak: an in-depth, qualitative research-based investigation of factors relevant to health-related quality of life in real-world patients with hereditary angioedema using subcutaneous C1 inhibitor replacement therapy.
    Anderson J; Levy DS; Lumry W; Koochaki P; Lanar S; Henry Li H
    Allergy Asthma Clin Immunol; 2021 Jun; 17(1):60. PubMed ID: 34176500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life among children with hereditary angioedema.
    Engel-Yeger B; Farkas H; Kivity S; Veszeli N; Kőhalmi KV; Kessel A
    Pediatr Allergy Immunol; 2017 Jun; 28(4):370-376. PubMed ID: 28258590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HAE-AS: A Specific Disease Activity Scale for Hereditary Angioedema With C1-Inhibitor Deficiency.
    Forjaz MJ; Ayala A; Caminoa M; Prior N; Pérez-Fernández E; Caballero T;
    J Investig Allergol Clin Immunol; 2021 Jun; 31(3):246-252. PubMed ID: 31932270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and screening of patients with hereditary angioedema in primary care.
    Henao MP; Kraschnewski JL; Kelbel T; Craig TJ
    Ther Clin Risk Manag; 2016; 12():701-11. PubMed ID: 27194914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review of Randomized Controlled Trials of Hereditary Angioedema Long-Term Prophylaxis with C1 Inhibitor Replacement Therapy: Alleviation of Disease Symptoms Is Achievable.
    Longhurst HJ; Valerieva A
    J Asthma Allergy; 2023; 16():269-277. PubMed ID: 36922963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical profile and treatment outcomes in patients with hereditary angioedema with normal C1 esterase inhibitor.
    Jones DH; Bansal P; Bernstein JA; Fatteh S; Harper J; Hsu FI; O'Connor M; Park N; Suez D
    World Allergy Organ J; 2022 Jan; 15(1):100621. PubMed ID: 35145604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Content validation and psychometric evaluation of the Angioedema Quality of Life Questionnaire for hereditary angioedema.
    Vanya M; Watt M; Shahraz S; Kosmas CE; Rhoten S; Costa-Cabral S; Mendivil J; Devercelli G; Weller K
    J Patient Rep Outcomes; 2023 Apr; 7(1):33. PubMed ID: 37012445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations.
    Gower RG; Lumry WR; Davis-Lorton MA; Johnston DT; Busse PJ
    Allergy Asthma Proc; 2012; 33(3):235-40. PubMed ID: 22584192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.